Conexeu Sciences Inc. (NASDAQ:CNXU) Sees Large Increase in Short Interest

Conexeu Sciences Inc. (NASDAQ:CNXU) saw a large increase in short interest in the month of August. As of August 31st, there was short interest totaling 202,485 shares, an increase of 56.4% from the August 15th total of 129,461 shares. Based on an average trading volume of 321,266 shares, the short-interest ratio is currently 0.6 days. Approximately 0.8% of the shares of the stock are sold short.

Conexeu Sciences Stock Performance

Shares of NASDAQ CNXU opened at $4.96 on Friday. Conexeu Sciences has a 1 year low of $4.19 and a 1 year high of $18.79. The stock’s 50-day simple moving average is $7.56. The stock has a market capitalization of $139.92 million and a price-to-earnings ratio of -45.09.

Conexeu Sciences (NASDAQ:CNXU) last announced its quarterly earnings results on Monday, September 14th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). On average, research analysts expect that Conexeu Sciences will post -0.4 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on CNXU shares. HC Wainwright began coverage on Conexeu Sciences in a research report on Monday, June 22nd. They issued a “buy” rating and a $20.00 price target for the company. Weiss Ratings assumed coverage on shares of Conexeu Sciences in a research note on Monday, August 17th. They issued a “sell (e-)” rating for the company. Zacks Research upgraded Conexeu Sciences to a “hold” rating in a report on Monday, June 29th. Finally, Wall Street Zen upgraded Conexeu Sciences to a “hold” rating in a report on Saturday, May 30th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $20.00.

About Conexeu Sciences

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. — Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property (“IP”) developed over more than a decade at the University of British Columbia (the “University”) and the BC Professional Firefighters Burn and Wound Healing Laboratory.